Diagnostic News and Research

RSS

Agilent, Integrated Diagnostics partner to improve protein-based LC/MS assays

Agilent Technologies Inc. and Integrated Diagnostics today announced a strategic partnership to develop assays that detect major human diseases at very early stages to improve treatment outcomes.

11 Jan 2012

Precise diagnostic algorithm for fibrosis in HCV patients reduces need for liver biopsy

A new classification for diagnosing fibrosis in patients with chronic hepatitis C virus (HCV) has shown to be as accurate as currently used algorithms, but required no further liver biopsy.

11 Jan 2012

Ortho Kinematics' KineGraph Vertebral Motion Analyzer receives FDA 510(k) clearance

Ortho Kinematics‚ a private company focused on revolutionizing spine motion analysis, announced receiving 510(k) clearance from the U.S. Food and Drug Administration for the KineGraph VMA (Vertebral Motion Analyzer) system. The KineGraph VMA system is designed to improve a test routinely prescribed by spine surgeons—the flexion/extension x-ray.

11 Jan 2012

Starpharma receives FDA Special Protocol Assessment for bacterial vaginosis phase 3

Starpharma today announced that it has received final written agreement from the FDA on the design of its Phase 3 clinical studies of VivaGel® for the treatment of bacterial vaginosis (BV) under the FDA’s Special Protocol Assessment (SPA) scheme.

10 Jan 2012

New fibrosis classification improves accuracy of diagnosis in Hepatitis C

A new classification for diagnosing fibrosis in patients with chronic hepatitis C virus (HCV) has shown to be as accurate as currently used algorithms, but required no further liver biopsy. The study appearing in the January issue of Hepatology, a journal published by Wiley-Blackwell on behalf of the American Association for the Study of Liver Diseases, details a method that synchronously combines two fibrosis tests, providing a non-invasive and more precise fibrosis diagnosis.

10 Jan 2012

QIAGEN's therascreen EGFR Mutation Detection Kit receives Japanese regulatory approval

QIAGEN today announced the regulatory approval of its therascreen EGFR Mutation Detection Kit RGQ in Japan. EGFR, the epidermal growth factor receptor, has been shown to play an important role in certain cancers and is the target of many new anticancer drugs.

From QIAGEN Manchester Limited 10 Jan 2012

RUMC moves 200 patients into new 14-story hospital building

After more than seven years of planning and three years of construction, Rush University Medical Center successfully moved approximately 200 patients into the Tower, Rush's new, 14-story, state-of-the-art hospital building, located at Ashland Avenue and the Eisenhower Expressway.

10 Jan 2012

Life Technologies takes orders for new benchtop Ion Proton Sequencer

Life Technologies Corporation today announced it is taking orders for the new benchtop Ion Proton Sequencer that is designed to sequence the entire human genome in a day for $1,000.

10 Jan 2012

Neomatrix, UND partner to develop technology for early detection of breast cancer

The University of North Dakota and Neomatrix, LLC, have signed an exclusive agreement to develop technology for the early detection of breast cancer using the company's HALO Breast Pap Test device.

9 Jan 2012

For physicians, the practice of medicine can pose business challenges

CNN reports that physicians sometimes have trouble owning a small business and the Miami Herald reports on how new technology might prove healthful.

9 Jan 2012

HDC, NeoGenomics sign worldwide licensing agreement to develop LDT

Health Discovery Corporation, a molecular diagnostics leader in the use of patent protected advanced mathematical techniques for personalized medicine, has entered into an exclusive worldwide licensing agreement with NeoGenomics, Inc. for laboratory developed tests in the Field of hematopoietic and solid tumor cancers excluding breast cancer, which was previously licensed to Quest Diagnostics and Smart Personalized Medicine and excluding cancer of the retina which was previously committed to Retinalyze, LLC.

9 Jan 2012

BerGenBio completes $8.8M Series A financing round

BerGenBio AS, an emerging oncology biopharma company, today announced it has completed an $8.8 million Series A financing round. The financing will be used primarily to take lead compound BGB324 into clinical trials and to develop a companion diagnostic.

9 Jan 2012

MPIIB, QIAGEN partner to develop latent TB diagnostic test

QIAGEN N.V. and the Max Planck Institute for Infection Biology (MPIIB), Department of Immunology have announced a new collaboration to develop a molecular diagnostic test to assess the risk of an individual with latent tuberculosis (TB) developing active TB disease during their lifetime.

From QIAGEN Manchester Limited 9 Jan 2012

Scientists develop simple, reliable test to identify biomarkers for MPS

A team of scientists, led by researchers at the University of California, San Diego School of Medicine and Zacharon Pharmaceuticals, have developed a simple, reliable test for identifying biomarkers for mucopolysaccharidoses (MPS), a group of inherited metabolic disorders that are currently diagnosed in patients only after symptoms have become serious and the damage possibly irreversible.

8 Jan 2012

Proteomics: Thermo Fisher Scientific and PREMIER Biosoft to co-market SimGlycan software

Thermo Fisher Scientific Inc., the world leader in serving science, and PREMIER Biosoft, have announced an agreement to co-market PREMIER Biosoft’s SimGlycan® software. The agreement aims to advance glycobiology by dramatically speeding the characterization of complex glycans through automated interpretation of the rich data produced by Thermo Scientific mass spectrometer systems.

From Thermo Fisher Scientific Inc. 8 Jan 2012

Great Prostate Cancer Challenge 5K Race to take place in Fort Myers on Jan. 28

Lace up your sneakers and join Florida Urology Physicians and ZERO — The Project to End Prostate Cancer on Saturday, January 28, 2012 for the Great Prostate Cancer Challenge 5K Race in Fort Myers. The Great Prostate Cancer Challenge is America's premier men's health event series, taking place in 33 cities in 2012.

7 Jan 2012

Acceptance increases for selective non-operative management of stab, gunshot wound patients

Although more patients with abdominal gunshot and stab wounds can successfully forego emergency "exploratory" surgery and its potential complications, new Johns Hopkins research suggests that choosing the wrong patients for this "watchful waiting" approach substantially increases their risk of death from these injuries.

7 Jan 2012

New Zealand life science and health IT companies to showcase their products in San Francisco

New Zealand is well known for its wines and stunning scenery, but the country is also a great source of innovation in the life sciences. A delegation of New Zealand life sciences companies who have reached key stages in their development are joining the throngs of international therapeutics, medical device and health IT companies in San Francisco, January 9 - 12 to showcase their products and capabilities to potential corporate partners and investors.

7 Jan 2012

Cardinal Health launches infusion room management tool for community rheumatologists

Cardinal Health Specialty Solutions today launched InfusaTrack, a Web-based infusion room management tool that makes it easier for community rheumatology practices to offer in-office infusion therapy services to patients.

7 Jan 2012

AccuGenomics to participate in OneMedForum at Sir Francis Drake hotel

AccuGenomics announced today that it will be attending the upcoming OneMedForum at the Sir Francis Drake hotel in San Francisco on January 9-12, coinciding with the JP Morgan Global Healthcare Conference.

7 Jan 2012

Diagnostic News and Research

Agilent, Integrated Diagnostics partner to improve protein-based LC/MS assays

Precise diagnostic algorithm for fibrosis in HCV patients reduces need for liver biopsy

Ortho Kinematics' KineGraph Vertebral Motion Analyzer receives FDA 510(k) clearance

Starpharma receives FDA Special Protocol Assessment for bacterial vaginosis phase 3

New fibrosis classification improves accuracy of diagnosis in Hepatitis C

QIAGEN's therascreen EGFR Mutation Detection Kit receives Japanese regulatory approval

RUMC moves 200 patients into new 14-story hospital building

Life Technologies takes orders for new benchtop Ion Proton Sequencer

Neomatrix, UND partner to develop technology for early detection of breast cancer

For physicians, the practice of medicine can pose business challenges

HDC, NeoGenomics sign worldwide licensing agreement to develop LDT

BerGenBio completes $8.8M Series A financing round

MPIIB, QIAGEN partner to develop latent TB diagnostic test

Scientists develop simple, reliable test to identify biomarkers for MPS

Proteomics: Thermo Fisher Scientific and PREMIER Biosoft to co-market SimGlycan software

Great Prostate Cancer Challenge 5K Race to take place in Fort Myers on Jan. 28

Acceptance increases for selective non-operative management of stab, gunshot wound patients

New Zealand life science and health IT companies to showcase their products in San Francisco

Cardinal Health launches infusion room management tool for community rheumatologists

AccuGenomics to participate in OneMedForum at Sir Francis Drake hotel

Industry Focus eBook - Cell biology (5th edition) eBook

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News